The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
ADC Therapeutics, Inc. Common H0036K147 9,357 344,519 SH   SOLE   344,519 0 0
Amicus Therapeutics Inc. Common 03152W109 5,220 546,558 SH   SOLE   546,558 0 0
Avadel Pharmaceuticals Plc Common 05337M104 3,920 400,000 SH   SOLE   400,000 0 0
AVROBIO, Inc. Common 05455M100 4,809 861,858 SH   SOLE   861,858 0 0
Axsome Therapeutics Inc. Common 05464T104 3,631 110,155 SH   SOLE   110,155 0 0
Biocryst Pharmaceuticals Inc. Common 09058V103 10,128 704,767 SH   SOLE   704,767 0 0
Black Diamond Therapeutics, Inc. Common 09203E105 2,102 248,506 SH   SOLE   248,506 0 0
Crinetics Pharmaceuticals Inc. Common 22663K107 6,281 298,392 SH   SOLE   298,392 0 0
Cullinan Oncology, Inc. Common 230031106 172,621 7,648,268 SH   SOLE   7,648,268 0 0
Cytokinetics Inc. Common 23282W605 8,838 247,291 SH   SOLE   247,291 0 0
Epizyme, Inc. Common 29428V104 20,341 3,972,830 SH   SOLE   3,972,830 0 0
ESSA Pharma, Inc. Common 29668H708 5,466 683,287 SH   SOLE   683,287 0 0
G1 Therapeutics, Inc. Common 3621LQ109 11,548 860,502 SH   SOLE   860,502 0 0
Geron Corporation Common 374163103 7,854 5,732,770 SH   SOLE   5,732,770 0 0
Harmony Biosciences Hldgs Inc. Common 413197104 5,813 151,650 SH   SOLE   151,650 0 0
Harpoon Therapeutics, Inc. Common 41358P106 25,254 3,196,707 SH   SOLE   3,196,707 0 0
Inozyme Pharma Inc. Common 45790W108 3,717 320,724 SH   SOLE   320,724 0 0
Intellia Therapeutics, Inc. Common 45826J105 21,815 162,620 SH   SOLE   162,620 0 0
iTeos Therapeutics, Inc. Common 46565G104 56,891 2,107,092 SH   SOLE   2,107,092 0 0
Lucira Health Inc. Common 54948U105 4,394 578,114 SH   SOLE   578,114 0 0
MEI Pharma, Inc. Common 552798202 34,484 12,494,118 SH   SOLE   12,494,118 0 0
Merus N.V. Common N5749R100 20,723 941,948 SH   SOLE   941,948 0 0
Mirum Pharmaceuticals Inc. Common 604749101 6,146 308,532 SH   SOLE   308,532 0 0
Neogenomics Inc. Common 64049M209 7,212 149,504 SH   SOLE   149,504 0 0
Oncorus, Inc. Common 68236R103 22,201 2,377,031 SH   SOLE   2,377,031 0 0
Repare Therapeutics, Inc. Common 760273102 43,030 1,639,849 SH   SOLE   1,639,849 0 0
Revolution Medicines, Inc. Common 76155X100 4,127 150,000 SH   SOLE   150,000 0 0
TCR2 Therapeutics, Inc. Common 87808K106 28,687 3,370,982 SH   SOLE   3,370,982 0 0
Travere Therapeutics Inc. Common 89422G107 7,433 306,515 SH   SOLE   306,515 0 0
Turning Point Therapeutics, Inc. Common 90041T108 18,026 271,350 SH   SOLE   271,350 0 0
Verastem, Inc. Common 92337C104 8,701 2,824,857 SH   SOLE   2,824,857 0 0
Werewolf Therapeutics, Inc. Common 95075A107 40,978 2,388,011 SH   SOLE   2,388,011 0 0
YmAbs Therapeutics, Inc. Common 984241109 12,928 452,970 SH   SOLE   452,970 0 0